Hasan Uludag
Hasan Uludag
Verified email at ualberta.ca - Homepage
Title
Cited by
Cited by
Year
Technology of mammalian cell encapsulation
H Uludag, P De Vos, PA Tresco
Advanced drug delivery reviews 42 (1-2), 29-64, 2000
7772000
Characterization of rhBMP‐2 pharmacokinetics implanted with biomaterial carriers in the rat ectopic model
H Uludag, D D'Augusta, R Palmer, G Timony, J Wozney
Journal of Biomedical Materials Research: An Official Journal of The Society …, 1999
2991999
Carrier systems for bone morphogenetic proteins.
SR Winn, H Uludag, JO Hollinger
Clinical Orthopaedics and Related Research (1976-2007) 367, S95-S106, 1999
2881999
Delivery systems for BMPs: factors contributing to protein retention at an application site
H Uludag, T Gao, TJ Porter, W Friess, JM Wozney
JBJS 83 (1_suppl_2), S128-S135, 2001
2772001
‘Magic bullets’ for bone diseases: progress in rational design of bone-seeking medicinal agents
S Zhang, G Gangal, H Uludağ
Chemical Society Reviews 36 (3), 507-531, 2007
2492007
Implantation of recombinant human bone morphogenetic proteins with biomaterial carriers: a correlation between protein pharmacokinetics and osteoinduction in the rat ectopic model
H Uludag, D D'Augusta, J Golden, J Li, G Timony, R Riedel, JM Wozney
Journal of Biomedical Materials Research: An Official Journal of The Society …, 2000
2302000
Sustained release emphasizing recombinant human bone morphogenetic protein-2
SR Winn, H Uludag, JO Hollinger
Advanced drug delivery reviews 31 (3), 303-318, 1998
2301998
Nanoparticulate systems for growth factor delivery
S Zhang, H Uludağ
Pharmaceutical research 26 (7), 1561-1580, 2009
1862009
Biodegradable amphiphilic poly (ethylene oxide)-block-polyesters with grafted polyamines as supramolecular nanocarriers for efficient siRNA delivery
XB Xiong, H Uludağ, A Lavasanifar
Biomaterials 30 (2), 242-253, 2009
1732009
Formulation and delivery of siRNA by oleic acid and stearic acid modified polyethylenimine
A Alshamsan, A Haddadi, V Incani, J Samuel, A Lavasanifar, H Uludag
Molecular pharmaceutics 6 (1), 121-133, 2009
1652009
Characterization of absorbable collagen sponges as rhBMP-2 carriers
W Friess, H Uludag, S Foskett, R Biron, C Sargeant
International journal of pharmaceutics 187 (1), 91-99, 1999
1651999
Aliphatic lipid substitution on 2 kDa polyethylenimine improves plasmid delivery and transgene expression
A Neamnark, O Suwantong, RB KC, CYM Hsu, P Supaphol, H Uludag
Molecular Pharmaceutics 6 (6), 1798-1815, 2009
1572009
Current state of fabrication technologies and materials for bone tissue engineering
A Wubneh, EK Tsekoura, C Ayranci, H Uludağ
Acta Biomaterialia 80, 1-30, 2018
1512018
Supramolecular assemblies in functional siRNA delivery: where do we stand?
HM Aliabadi, B Landry, C Sun, T Tang, H Uludağ
Biomaterials 33 (8), 2546-2569, 2012
1472012
Bisphosphonates as a foundation of drug delivery to bone
H Uludag
Current pharmaceutical design 8 (21), 1929-1944, 2002
1402002
Multifunctional polymeric micelles for enhanced intracellular delivery of doxorubicin to metastatic cancer cells
XB Xiong, A Mahmud, H Uludağ, A Lavasanifar
Pharmaceutical research 25 (11), 2555-2566, 2008
1252008
Recent developments in nanoparticle-based drug delivery and targeting systems with emphasis on protein-based nanoparticles
G Wang, H Uludag
Expert Opinion on Drug Delivery 5 (5), 499-515, 2008
1232008
Growth factor delivery for bone tissue engineering
SA Gittens, H Uludag
Journal of drug targeting 9 (6), 407-429, 2001
1192001
Lipid and hydrophobic modification of cationic carriers on route to superior gene vectors
V Incani, A Lavasanifar, H Uludağ
Soft Matter 6 (10), 2124-2138, 2010
1182010
Conjugation of Arginine-Glycine-Aspartic Acid Peptides to Poly(ethylene oxide)-b-poly(ε-caprolactone) Micelles for Enhanced Intracellular Drug Delivery to …
XB Xiong, A Mahmud, H Uludaǧ, A Lavasanifar
Biomacromolecules 8 (3), 874-884, 2007
1172007
The system can't perform the operation now. Try again later.
Articles 1–20